<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:24.0pt;
font-family:"Times New Roman",serif;
font-weight:bold;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:18.0pt;
font-family:"Times New Roman",serif;
font-weight:bold;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
margin-top:2.0pt;
margin-right:0cm;
margin-bottom:0cm;
margin-left:0cm;
margin-bottom:.0001pt;
page-break-after:avoid;
font-size:12.0pt;
font-family:"Calibri Light",sans-serif;
color:#1F4D78;
mso-fareast-language:EN-US;
font-weight:normal;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
{mso-style-priority:99;
mso-style-link:"Body Text Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;
mso-fareast-language:EN-US;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
{mso-style-priority:11;
mso-style-link:"Subtitle Char";
margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
color:#5A5A5A;
letter-spacing:.75pt;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
address
{mso-style-priority:99;
mso-style-link:"HTML Address Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman",serif;
font-style:italic;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:36.0pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:36.0pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
span.HTMLAddressChar
{mso-style-name:"HTML Address Char";
mso-style-priority:99;
mso-style-link:"HTML Address";
font-style:italic;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Times New Roman",serif;
mso-fareast-language:EN-ZW;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Times New Roman",serif;
mso-fareast-language:EN-ZW;
font-weight:bold;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Calibri Light",sans-serif;
color:#1F4D78;
mso-fareast-language:EN-US;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.BodyTextChar
{mso-style-name:"Body Text Char";
mso-style-priority:99;
mso-style-link:"Body Text";
font-family:"Times New Roman",serif;}
span.SubtitleChar
{mso-style-name:"Subtitle Char";
mso-style-priority:11;
mso-style-link:Subtitle;
font-family:"Calibri",sans-serif;
color:#5A5A5A;
letter-spacing:.75pt;}
p.pb15, li.pb15, div.pb15
{mso-style-name:pb15;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle30
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.style30
{mso-style-name:style30;}
span.EmailStyle32
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.updated-wrap
{mso-style-name:updated-wrap;}
span.updated-text
{mso-style-name:updated-text;}
span.vjs-control-text
{mso-style-name:vjs-control-text;}
span.vjs-current-time-display
{mso-style-name:vjs-current-time-display;}
span.vjs-duration-display
{mso-style-name:vjs-duration-display;}
span.link600907a1
{mso-style-name:link__600907a1;}
span.pricechangea4e5ebde
{mso-style-name:pricechange__a4e5ebde;}
span.percentchange4644dd7b
{mso-style-name:percentchange__4644dd7b;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-ZW link="#0563C1" vlink="#954F72"><div class=WordSection1><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=916 style='width:687.2pt;border-collapse:collapse'><tr><td width=910 colspan=4 valign=top style='width:682.8pt;padding:0cm 5.4pt 0cm 5.4pt'></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:solid #D9D9D9 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='text-indent:33.35pt;line-height:105%'><a href="https://bullszimbabwe.com/"><span style='font-family:"Verdana",sans-serif;color:windowtext;mso-fareast-language:EN-ZW;text-decoration:none'><img border=0 width=246 height=120 id="Picture_x0020_5" src="cid:image001.png@01D6F95D.774DCAF0" alt="cid:image001.png@01D6F95D.774DCAF0"></span></a><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='margin-left:32.1pt;text-indent:7.5pt;line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif;color:#002060'><o:p> </o:p></span></b></p><p class=MsoNormal><span style='color:#1F497D'><a href="http://www.bullszimbabwe.com"><span style='text-decoration:none'>Bullszimbabwe.com </span></a> <a href="mailto:info@bulls.co.zw?subject=View%20and%20Comments"><span style='text-decoration:none'>Views & Comments</span></a> <a href="https://bullszimbabwe.com/category/blogs/bullish-thoughts/"><span style='text-decoration:none'>Bullish Thoughts</span></a> <a href="http://www.twitter.com/BullsBears2010"><span style='text-decoration:none'>Twitter</span></a> <a href="https://www.facebook.com/BullsBearsZimbabwe"><span style='text-decoration:none'>Facebook</span></a> <a href="http://www.linkedin.com/pub/bulls-n-bears-zimbabwe/57/577/72"><span style='text-decoration:none'>LinkedIn</span></a> <a href="https://chat.whatsapp.com/CF6wllAfScU9Wr6dXxoQnO"><span style='text-decoration:none'>WhatsApp</span></a> <a href="mailto:info@bulls.co.zw?subject=Unsubscribe"><span style='text-decoration:none'>Unsubscribe</span></a></span><o:p></o:p></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> </span><span style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoSubtitle style='margin-left:32.1pt;text-indent:7.5pt;line-height:105%'><span class=style30><b><span style='color:black'><o:p> </o:p></span></b></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> </span><o:p></o:p></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span class=style30><b><span lang=EN-US style='font-family:"Verdana",sans-serif;color:#1F497D'>Coronavirus Global Updates, Feb 03::::Glaxo Joins CureVac; WHO Experts Visit Wuhan Lab</span></b></span><b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></b></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span class=style30><b><o:p> </o:p></b></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> </span><o:p></o:p></p></td></tr><tr style='height:3.0pt'><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:3.0pt'><p class=MsoNormal style='text-indent:33.35pt;line-height:105%'><a href="https://www.nicozdiamond.co.zw/"><b><span style='font-family:"Verdana",sans-serif;color:windowtext;mso-fareast-language:EN-ZW;text-decoration:none'><img border=0 width=809 height=268 id="Picture_x0020_4" src="cid:image003.jpg@01D6FA37.0A3B44D0"></span></b></a><span class=style30><b><o:p></o:p></b></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.0pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> </span><o:p></o:p></p></td></tr><tr style='height:10.05pt'><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr style='height:10.05pt'><td width=910 colspan=4 rowspan=3 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:10.05pt'><h1 style='line-height:33.75pt;background:white'><span lang=EN-US style='font-size:11.0pt;font-family:"Verdana",sans-serif;mso-fareast-language:EN-US'>Zimbabwe COVID19 Update<o:p></o:p></span></h1><h1 style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:105%;background:white'><span style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:#0F1419;font-weight:normal'>COVID-19 update: As at 02 February 2021, Zimbabwe had 33 814 confirmed cases, including 26 794 recoveries and 1 254 deaths.<o:p></o:p></span></h1><h1 style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:105%;background:white'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:#1F497D;mso-fareast-language:EN-US'><o:p> </o:p></span></h1><h1 style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:105%;background:white'><span style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:#1F497D'><img border=0 width=592 height=817 id="Picture_x0020_3" src="cid:image004.jpg@01D6FA36.E5C43F30" alt=Image></span><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:black;mso-fareast-language:EN-US'><o:p></o:p></span></h1><h1 style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:105%;background:white'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:black;mso-fareast-language:EN-US'><o:p> </o:p></span></h1><h1 style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:15.0pt;margin-left:0cm;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black;letter-spacing:-.3pt'>Glaxo Joins CureVac; WHO Experts Visit Wuhan Lab: Virus Update<o:p></o:p></span></h1><p class=MsoNormal style='background:white;vertical-align:baseline'><span style='font-family:"Verdana",sans-serif;color:#1ECD93'><o:p> </o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'><a href="https://www.bloomberg.com/quote/GSK:LN" title="Company Overview"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>GlaxoSmithKline Plc</span></a> will work with CureVac NV to help boost production of its experimental vaccine and improve the shot to help protect against multiple variants of the pathogen.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>A World Health Organization team visited the Wuhan laboratory that’s been at the center of months of speculation over how the disease jumped to humans.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>U.K. Health Secretary Matt Hancock said the 2011 movie “Contagion,” depicting the breakdown of society during a pandemic, influenced his planning for the vaccines rollout. AstraZeneca Plc’s vaccine showed 82% effectiveness with a <a href="https://www.bloomberg.com/news/articles/2021-02-02/astra-vaccine-shows-82-efficacy-with-3-month-gap-oxford-says" target="_blank" title="Astra Shot Shows 82% Efficacy With U.K.’s Two-Dose Interval (2)"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>three-month gap</span></a> between two shots in a study that bolstered the U.K.’s controversial decision to extend the interval between doses.<o:p></o:p></span></p><p class=MsoNormal style='background:white;vertical-align:baseline'><b><span style='font-family:"Verdana",sans-serif;color:black'>Israel Widens Vaccination Drive to Young Adults </span></b><span class=MsoHyperlink><span style='border:none windowtext 1.0pt;padding:0cm;text-decoration:none'><o:p></o:p></span></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Israel’s Health Ministry has instructed the country’s health-service providers to prepare to extend their vaccination drive to all people over the age of 16 starting Thursday.</span><span style='font-size:11.0pt;color:black'><o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The expected change will mean that people aged 19-35 will officially be eligible to be inoculated. Israel began its vaccination drive with people over the age of 60 and has gradually been reducing the minimum eligible age.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=antibodies-remain-six-months-after-infection-study-shows-5-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Antibodies Remain Six Months After Infection, Study Shows<o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The vast majority of people who contract Covid-19 still have antibodies at least six months after infection, a new study involving more than 20,000 people showed.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Some 88% of participants who tested positive for a previous infection retained antibodies for six months, according to the report by <span style='border:none windowtext 1.0pt;padding:0cm'>UK</span> Biobank, a major biomedical database. The number was 99% at three months.<o:p></o:p></span></p><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The results follow other, smaller studies that indicate a level of immunity following a natural infection for at least 6 months. Health officials have said it’s still unclear how long protection through vaccines could last.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=contagion-movie-shaped-uks-vaccine-rollout-455-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>‘Contagion’ Movie Shaped U.K.’s Vaccine Rollout<o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>U.K. Health Secretary Matt Hancock said the 2011 movie “Contagion,” depicting the breakdown of society during a pandemic, influenced his planning for the rollout of coronavirus vaccines.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>“In the film, it shows the moment of highest stress around the vaccine program is not in fact before it’s rolled out,” Hancock told LBC radio on Wednesday. “It’s <span style='border:none windowtext 1.0pt;padding:0cm'>afterwards</span>, when there is a huge row about the order of priority.” The British government asked for “very early” clinical advice on who should get the shots first and laid it out to the public, he said.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=france-blasts-hungary-for-vaccine-approach-416-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'><br>France Blasts Hungary for Vaccine Approach <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>France condemned Hungary for a go-it-alone approval of Russian and Chinese vaccines outside the European Union process.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Hungary is “carrying out its own procedures with Russia and China” while benefiting from the EU’s supply process, Clement Beaune, junior minister for EU affairs, said Wednesday on LCI television. Instead, he suggested that Russia should submit its Sputnik V vaccine to European regulators to ensure it’s vetted according to the same criteria as others.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>“The Russians haven’t submitted their vaccine to European authorities and we would invite them to do so,” he said.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=moderna-vaccine-authorized-for-use-in-singapore-410-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Moderna Vaccine Authorized for Use in Singapore <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Singapore approved Moderna Inc.’s vaccine for use in the country with an interim clearance. A review of the clinical data found that benefits of the vaccine outweigh any known risks, according to Singapore’s Health Sciences Authority.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=china-ready-to-provide-10m-vaccine-doses-to-covax-342-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>China Ready to Provide 10M Vaccine Doses to Covax <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>China said it’s ready to supply 10 million coronavirus vaccine doses to the Covax effort, primarily for emergency use in developing countries, Foreign Ministry spokesman Wang Wenbin said at a briefing in Beijing.<o:p></o:p></span></p><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>China late last year said it would take part in the World Health Organization-backed plan to provide a vaccine to developing nations, filling a void in global health leadership after U.S. President Donald Trump spurned the program.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=sinopharm-zhifei-vaccines-work-against-covid-variant-331-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Sinopharm, Zhifei Vaccines Work Against Covid Variant <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The vaccines developed by Sinopharm and Zhifei Biological work against the variant found in South Africa but with slightly weaker protection, Jiemian.com reported. The report cited an article by authors including George Gao Fu, head of China’s Center for Disease Control and Prevention.<o:p></o:p></span></p><h3 style='margin-top:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=glaxo-curevac-team-up-to-develop-nextgeneration-shots-325-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Glaxo, CureVac Team <span style='border:none windowtext 1.0pt;padding:0cm'>Up to</span> Develop Next-Generation Shots <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>GlaxoSmithKline and CureVac will work together to create next-generation messenger RNA vaccines. The companies aim to have a candidate approved by 2022 as part of a 150 million euro ($180 million) deal, they said in a statement.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Glaxo will also manufacture as much as 100 million doses of CureVac’s current mRNA vaccine, which is in late-stage trials. Drugmakers are looking to accelerate the development of shots as new variants emerge, sparking fears some vaccines could become less effective.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=myanmar-vaccine-effort-continues-amid-protest-240-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Myanmar Vaccine Effort Continues Amid Protest <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Myanmar’s vaccine roll-out is set to continue uninterrupted even though a section of medical workers and doctors are halting work to protest the coup, according to Khin Khin Gyi, director of emerging infectious disease at the Ministry of Health and Sports.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The country inoculated more than 80,000 health workers, volunteers and officials in the first week of the vaccination drive and is set to receive 2 million doses of AstraZeneca vaccines produced by the Serum Institute of India on Feb. 11. Another batch of 4.2 million shots from the global Covax effort is scheduled before the end of the month.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=taiwan-to-delay-school-opening-hong-kong-considers-capacity-boost-220-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Taiwan to Delay School Opening, Hong Kong Considers Capacity Boost <o:p></o:p></span></b></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Opening day for Taiwanese schools <a href="https://www.bloomberg.com/news/terminal/QNXVXWDWX2PW" target="_blank" title="Taiwan Extends School Winter Break to Feb. 22 Due to Virus"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>will be delayed</span></a> to Feb. 22 from Feb. 18, Minister of Education Pan Wen-chung said in a briefing. The extension of the winter break will allow schools to complete disinfection and virus-containment preparations.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Hong Kong is considering <span style='border:none windowtext 1.0pt;padding:0cm'>whether to allow</span> <span style='border:none windowtext 1.0pt;padding:0cm'>up to</span> one-third of a school’s student capacity to return to classes on a half-day basis after the Lunar New Year holidays, the South China Morning Post reported, citing unidentified people. Currently no more than a sixth of student capacity is allowed.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=who-team-visits-wuhan-virology-lab-1235-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>WHO Team Visits Wuhan Virology Lab<o:p></o:p></span></b></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>A WHO scientific team in China <a href="https://www.bloomberg.com/news/articles/2021-02-03/who-experts-visit-wuhan-lab-at-center-of-virus-conspiracy-theory" target="_blank" title="WHO Experts Visit Wuhan Lab at Center of Virus Conspiracy Theory"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>to investigate the origins</span></a> of the coronavirus visited the Wuhan laboratory that’s been at the center of months of speculation over how the disease jumped to humans. The scientists arrived at the Wuhan Institute of Virology, home to a high-tech laboratory that studies some of the world’s most infectious diseases, on Wednesday morning.<o:p></o:p></span></p><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The team is “looking forward to a very productive day and to asking all the questions that we know need to be asked,” Peter Daszak, a New York-based zoologist who is part of both the WHO and The Lancet teams trying to trace the virus’s origin, told reporters, Agence France-Presse reported.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>In the past week, the experts have also visited the Huanan seafood market where the first infections emerged, two major Wuhan hospitals that treated patients when it was unknown what they were afflicted with, and an animal disease center.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=yellen-speaks-with-world-officials-on-covid-1145-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Yellen Speaks With World Officials on Covid <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>U.S. Treasury Secretary Janet Yellen has been speaking with numerous global officials about Covid-19, including World Bank President David Malpass and the International Monetary Fund Managing Director Kristalina Georgieva. Mexico’s Finance Minister Arturo Herrera said he spoke with her on vaccine strategy.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Yellen <a href="https://www.bloomberg.com/news/terminal/QNXD31T1UM0W" target="_blank" title="Yellen Sees Years Before U.S. Reaches Full Employment Again"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>said in a statement</span></a> that Monday’s Congressional Budget Office forecast underscores that “we desperately need Congress to act on a rescue package.” The growth <a href="https://www.bloomberg.com/news/articles/2021-02-01/cbo-sees-a-stronger-u-s-recovery-after-stimulus-moves-in-2020" target="_blank" title="Economy Rebounding More Quickly, CBO Says, Clouding Biden Plans"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>projected by the CBO</span></a> means “it will be years before the country reaches full employment again,” she said.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=singapore-bolsters-foreignworker-testing-measures-1035-am><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Singapore Bolsters Foreign-Worker Testing Measures <o:p></o:p></span></b></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Singapore is <span style='border:none windowtext 1.0pt;padding:0cm'>adding foreign-worker testing measures</span>, according to a government statement. Some newly arrived workers from the construction, marine and process sectors who have recent travel history to higher-risk countries will have to stay at a designated facility to go through an additional seven-day testing regime after completing their mandatory 14-day quarantine period.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Foreign domestic workers and confinement nannies who have recent travel history to higher-risk countries will also have to take an on-arrival serology test in addition to the existing PCR test.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=cricket-australia-postpones-tour-of-south-africa-1015-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Cricket Australia Postpones Tour of South Africa <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Australian cricket’s governing body said it had no choice but to delay the tour of South Africa due to the pandemic amid a second wave and new variant of the virus. Cricket Australia Interim CEO Nick Hockley said the decision was not “made lightly” and that there are plans to complete the tour at a later date.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>South Africa remains on <span style='border:none windowtext 1.0pt;padding:0cm'>virus alert level 3</span>, although it has begun easing restrictions and a ban on alcohol sales as the positivity rate declines to less than 20% from a peak of 36% last month.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'><o:p> </o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=new-zealand-approves-pfizerbiontech-vaccine-940-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>New Zealand Approves Pfizer-BioNTech Vaccine <o:p></o:p></span></b></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>New Zealand’s medicines regulator <span style='border:none windowtext 1.0pt;padding:0cm'>has approved</span> the Pfizer-BioNTech vaccine for domestic use once it arrives in the country. The approval is provisional on the drug companies keeping the authority updated with data from clinical trials and manufacturing processes.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'><o:p> </o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=thai-resort-island-draws-up-vaccine-plans-740-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Thai Resort Island Draws Up Vaccine Plans <o:p></o:p></span></b></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>A Thai resort island popular for its beaches <span style='border:none windowtext 1.0pt;padding:0cm'>is drawing up plans</span> to fully reopen to vaccinated visitors by October to revive its tourism industry. More than a dozen business groups are planning to pool funds to vaccinate 70% of the island’s adult population without waiting for a government rollout. They are betting that it’ll be safe to open the region to foreign tourists once the local population achieves herd immunity.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'><o:p> </o:p></span></p><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The plan, which will need government approval, also seeks to waive a mandatory 14-day quarantine requirement, a major hurdle for many potential travelers.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=singapore-approves-using-tracing-data-in-some-criminal-probes-735-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Singapore Approves Using Tracing Data in Some Criminal Probes <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Singapore passed legislation late Tuesday that will allow the government to use Covid-19 tracing data in certain criminal investigations, formalizing legal powers that had sparked controversy. The new law allows access to contact-tracing data under seven categories of serious crime including murder, rape and drug trafficking. It also covers other contact tracing systems like SafeEntry, a national digital check-in system which provides a record of people who enter and exit venues.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Members of parliament who supported the bill said it was wrong to deny police another tool to solve serious crimes. Some critics said Singapore’s decision could signal the privacy risks of participating in contact-tracing programs, discouraging people from using technology at the heart of stopping Covid-19.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=us-looks-to-prevent-supply-shortages-640-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>U.S. Looks to Prevent Supply Shortages <o:p></o:p></span></b></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>U.S. President Joe Biden will order a <span style='border:none windowtext 1.0pt;padding:0cm'>government-wide review</span> of critical supply chains in an effort to reduce U.S. reliance on countries such as China for essential medical supplies and minerals, according to people familiar with the matter.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The administration’s goal is to protect government and private-sector supply chains to prevent future shortages and limit other countries’ ability to exert leverage over the U.S., according to an administration official.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=southern-africa-needs-vaccines-group-says-535-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Southern Africa Needs Vaccines, Group Says <br><br></span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Doctors Without Borders said Southern Africa is in dire need of vaccine doses, and called for more-equitable distribution of shots with health workers and people at highest risk given priority.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>“Health workers in Mozambique, Eswatini, and Malawi are currently struggling to treat escalating numbers of patients with little prospect of receiving a vaccine to protect themselves or others from the virus,” the group said in a statement.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=france-sees-vaccines-for-all-by-summers-end-505-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>France Sees Vaccines for All by Summer’s End <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>French President Emmanuel Macron said that based on contracts secured at a European level, France will be able to offer vaccination to all adults who want it “by the end of summer.”<o:p></o:p></span></p><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>All nursing home residents who want to the shot will have it by early March, representing about 500,000 people, he said. Macron called on the French to keep up preventive measures, saying the vaccination won’t end a lockdown or relieve pressure on hospitals. “The virus is circulating at great speed,” he said.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>France’s National Authority for Health recommended giving AstraZeneca Plc’s vaccine to people younger than 65.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=dutch-lockdown-extended-until-march-252-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Dutch Lockdown Extended Until March <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The lockdown in the Netherlands will be extended until March 2, said Dutch Prime Minister Mark Rutte.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Despite decreasing infections since Christmas, Rutte warned of “an inevitable third wave” because the British mutation accounts for about two-thirds of all new infections. A relaxation of measures would have been possible if it weren’t for the variant, he said.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Rutte did announce a reopening of elementary schools from Feb. 8, stating that the risk is limited. The night-time curfew will remain in place until Feb. 10, and Rutte said his government will decide early next week whether an extension is needed.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=ireland-reports-death-record-as-surge-eases-210-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Ireland Reports Death Record as Surge Eases <o:p></o:p></span></b></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Ireland recorded 101 virus related deaths on Tuesday, the highest since the pandemic began, health authorities said. The nation had battled one of the world’s worst outbreaks last month, which is now showing signs of easing. Daily infections dropped to 879, the lowest in over a month.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=astra-shot-shows-82-efficacy-with-3month-gap-2-am-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Astra Shot Shows 82% Efficacy With 3-Month Gap <o:p></o:p></span></b></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>AstraZeneca Plc’s vaccine showed 82% effectiveness with a <span style='border:none windowtext 1.0pt;padding:0cm'>three-month gap</span> between two shots, according to a new study that bolsters the U.K.’s controversial decision to adopt the extended dosing interval.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The vaccine also may significantly reduce transmission of the virus, according to analysis of trial data by the University of Oxford, which developed the vaccine with the U.K. drugmaker. Swabs taken from volunteers in the U.K. arm of the trial showed a 67% reduction in transmission after the first dose, the report showed.<o:p></o:p></span></p><p class=MsoListParagraphCxSpFirst style='background:white'><span style='font-family:"Verdana",sans-serif;color:#222222;mso-fareast-language:EN-ZW'><o:p> </o:p></span></p><p class=MsoListParagraphCxSpLast style='background:white'><span style='font-family:"Verdana",sans-serif;color:#222222;mso-fareast-language:EN-ZW'><o:p> </o:p></span></p><p class=MsoNormal style='line-height:105%;background:white'><span style='font-family:"Verdana",sans-serif;color:#222222;mso-fareast-language:EN-ZW'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:10.05pt'><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:10.05pt'><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:10.05pt'><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:10.05pt'><p class=MsoNormal style='text-indent:33.35pt;line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p> </o:p></span></p><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;margin-left:36.0pt;line-height:115%;background:white'><b><span style='font-family:"Verdana",sans-serif;color:#222222;mso-fareast-language:EN-ZW'><o:p> </o:p></span></b></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr><td width=910 colspan=4 style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='line-height:105%'><strong><span lang=EN-US style='font-family:"Verdana",sans-serif;color:#345883'>INVESTORS DIARY 2021</span></strong><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr style='height:3.25pt'><td width=175 style='width:131.3pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='text-indent:12.6pt;line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif'>Company</span></b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=207 style='width:155.5pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif'>Event</span></b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif'>Venue</span></b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=175 valign=bottom style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif'>Date & Time</span></b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr style='height:3.25pt'><td width=175 valign=top style='width:131.3pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=207 style='width:155.5pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=175 valign=top style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='margin-left:72.0pt;text-indent:-72.0pt;line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=175 valign=top style='width:131.3pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=207 style='width:155.5pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=175 valign=top style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='margin-left:72.0pt;text-indent:-72.0pt;line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=382 colspan=2 valign=top style='width:286.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><b><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:black'>Companies under Cautionary<o:p></o:p></span></b></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><b><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:black'><o:p> </o:p></span></b></p></td><td width=175 valign=bottom style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><b><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:black'><o:p> </o:p></span></b></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=382 colspan=2 valign=top style='width:286.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=175 valign=bottom style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=382 colspan=2 valign=top style='width:286.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>ART<o:p></o:p></span></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>PPC<o:p></o:p></span></p></td><td width=175 valign=bottom style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Dairibord<o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr style='height:3.25pt'><td width=382 colspan=2 valign=top style='width:286.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Starafrica<o:p></o:p></span></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Fidelity<o:p></o:p></span></p></td><td width=175 valign=bottom style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Turnall<o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=382 colspan=2 valign=top style='width:286.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Medtech<o:p></o:p></span></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Zimre<o:p></o:p></span></p></td><td width=175 valign=bottom style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Nampak Zimbabwe<o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=382 colspan=2 valign=top style='width:286.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=353 style='width:264.7pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=175 valign=bottom style='width:131.3pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:99.35pt'><td width=910 colspan=4 style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:99.35pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:99.35pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#1F497D;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><i><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></i></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#1F497D;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><i><span lang=EN-US style='font-size:8.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:white'>DISCLAIMER: This report has been prepared by Bulls ‘n Bears, a division of Faith Capital (Pvt) Ltd for general information purposes only and does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities. The information contained in this report has been compiled from sources believed to be reliable, but no representation or warranty is made or guarantee given as to its accuracy or completeness. All opinions expressed and recommendations made are subject to change without notice. Securities or financial instruments mentioned herein may not be suitable for all investors. Securities of emerging and mid-size growth companies typically involve a higher degree of risk and more volatility than the securities of more established companies. Neither Faith Capital nor any other member of Bulls ‘n Bears nor any other person, accepts any liability whatsoever for any loss howsoever arising from any use of this report or its contents or otherwise arising in connection therewith. Recipients of this report shall be solely responsible for making their own independent investigation into the business, financial condition and future prospects of any companies referred to in this report. Other Indices quoted herein are for guideline purposes only and sourced from third parties.</span></i><i><span lang=EN-US style='font-size:8.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p></o:p></span></i></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><i><span lang=EN-GB style='font-family:"Verdana",sans-serif;color:white'><o:p> </o:p></span></i></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=top style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'>(c) 2021 <b>Web</b>:<a href="http://www.bullszimbabwe.com"><span style='color:black;text-decoration:none'> www.bullszimbabwe.com </span></a><b>Email:</b> <a href="mailto:info@bulls.co.zw"><span style='color:black;text-decoration:none'>info@bulls.co.zw</span></a> <b>Tel:</b> +263 4 2927658 <b>Cell:</b> +263 77 344 1674<o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=910 colspan=4 valign=bottom style='width:682.8pt;border:solid #BFBFBF 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr></table></div><p class=MsoNormal><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></div></body></html>